Search
for
Sort by
Research 271–300 of 811
- Polycystic ovarian syndrome
- Innovative Uses for Zinc in Dermatology
- Specialization and the Physician Workforce
- Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial
- Interventions for morphea
- Skin disease in pregnancy
- Hormone therapy in acne
- The Use of Hormonal Antiandrogen Therapy in Female Patients with Acne: A 10-Year Retrospective Study
- Conventional and novel stem cell based therapies for androgenic alopecia
- Contraceptive use in acne
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Are there temporal subtypes of premenstrual dysphoric disorder?: using group-based trajectory modeling to identify individual differences in symptom change
- Topical use of systemic drugs in dermatology: A comprehensive review
- Chapter 17. Selective androgen receptor modulators (SARMs)
- Disinfection, sterilization and operation theater guidelines for dermatosurgical practitioners in India
- Therapeutic options in the polycystic ovary syndrome
- Cross-sex hormone therapy in Australia: the prescription patterns of clinicians experienced in adult transgender healthcare
- Top Ten List of Clinical Pearls in the Treatment of Acne Vulgaris
- Common Dermatologic Conditions
- Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary Syndrome
- Polycystic Ovary Syndrome
- Interventional studies for polycystic ovarian syndrome in children and adolescents
- The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms – a review
- Impact of Alpha Blockers, 5-alpha Reductase Inhibitors and Combination Therapy on Sexual Function
- Exclusive androgenic effect of dehydroepiandrosterone in sebaceous glands of rat skin
- Polycystic Ovary Syndrome
- The Biology of Hair Growth
- Choice of treatment for women with polycystic ovary syndrome
- Polymeric micelle mediated follicular delivery of spironolactone: Targeting the mineralocorticoid receptor to prevent glucocorticoid-induced activation and delayed cutaneous wound healing
- Uso de la espironolactona en dermatología: acné, hidradenitis supurativa, alopecia femenina e hirsutismo